Center-Authored Papers

Filters: Author is Gopal, A K  [Clear All Filters]
Journal Article
Green DJ, Bensinger WI, Holmberg LA, Gooley T, Till BG, Budde LE, Pagel JM, Frayo SL, Roden JE, Hedin L et al..  2016.  Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma.. Bone marrow transplantation. Abstract
Zhao B, Chen R, O'Connor OA, Gopal AK, Ramchandren R, Goy A, Matous JV, Fasanmade AA, Manley TJ, Han TH.  2016.  Brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive haematologic malignancies and hepatic or renal impairment.. British journal of clinical pharmacology. 82(3):696-705. Abstract
Gopal AK, Press OW.  1999.  Clinical applications of anti-CD20 antibodies.. The Journal of laboratory and clinical medicine. 134(5):445-50.
Gopal AK, Gooley TA, Golden JB, Maloney DG, Bensinger WI, Petersdorf SH, Appelbaum FR, Press OW.  2001.  Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.. Bone marrow transplantation. 27(6):593-9. Abstract
Pham RN, Gooley TA, Keeney GE, Press OW, Pagel JM, Greisman HA, Bensinger WI, Holmberg LA, Petersdorf SH, Maloney DG et al..  2007.  The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma.. Bone marrow transplantation. 40(11):1039-44. Abstract
Graf SA, Stevenson PA, Holmberg LA, Till BG, Press OW, Chauncey TR, Smith SD, Philip M, Orozco JJ, Shustov AR et al..  2015.  Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma.. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 26(11):2323-8. Abstract
Gauthier J, Holmberg L, Wu D, Bensinger W, Gopal AK, Press O, Maloney D, Green DJ, Till BG, Byelykh D et al..  2016.  Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas.. Bone marrow transplantation.
Press OW, Eary JF, Gooley T, Gopal AK, Liu S, Rajendran JG, Maloney DG, Petersdorf S, Bush SA, Durack LD et al..  2000.  A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.. Blood. 96(9):2934-42. Abstract
Gopal AK, Fanale MA, Moskowitz CH, Shustov AR, Mitra S, Ye W, Younes A, Moskowitz AJ.  2017.  Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma.. Annals of oncology : official journal of the European Society for Medical Oncology. Abstract
Bensinger WI, Becker PS, Gooley TA, Chauncey TR, Maloney DG, Gopal AK, Green DJ, Press OW, Lill M, Ifthikharuddin JJ et al..  2016.  A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT.. Bone marrow transplantation. 51(1):67-71. Abstract
Shan D, Gopal AK, Press OW.  2001.  Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.. Clinical cancer research : an official journal of the American Association for Cancer Research. 7(8):2490-5. Abstract